These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5534905)

  • 1. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. I. Somatic findings].
    Olbrich G
    Padiatr Grenzgeb; 1970; 9(3):157-61. PubMed ID: 5534905
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. IV. Neurologic and electroencephalographic findings].
    Müller K
    Padiatr Grenzgeb; 1970; 9(3):187-95. PubMed ID: 5534908
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. 3. Intellectual and psychic evaluation].
    Olbrich G
    Padiatr Grenzgeb; 1970; 9(3):176-86. PubMed ID: 5534907
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. V. ORL and audiometric findings].
    Matz J
    Padiatr Grenzgeb; 1970; 9(3):196-201. PubMed ID: 5534909
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. II. Stomatologic findings].
    Solyga P
    Padiatr Grenzgeb; 1970; 9(3):162-75. PubMed ID: 5534906
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. VII. Indications for exchange transfusion in Rh-incompatibility].
    Schneeweiss B
    Padiatr Grenzgeb; 1970; 9(3):208-17. PubMed ID: 4997628
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical follow-up on late prognosis of Rh-related hemolytic disease of the newborn].
    Schneeweiss B; Klemm PG; Matz J; Müller K; Olbrich G; Otto FM; Solyga P
    Padiatr Grenzgeb; 1970; 9(3):149-56. PubMed ID: 4997627
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical follow-up studies on late prognosis of Rh-related hemolytic diseases of the newborn. VI. Factor analysis for the catamnestic evaluation of Rh-related hemolytic disease of the newborn].
    Klemm PG
    Padiatr Grenzgeb; 1970; 9(3):202-7. PubMed ID: 5534910
    [No Abstract]   [Full Text] [Related]  

  • 9. [Follow-up studies following early infantile hemolytic disease of the newborn].
    Dördelmann P; Mowassaghi A
    Zentralbl Gynakol; 1966 Dec; 88(50):1697-701. PubMed ID: 6011591
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long term psychological observation of children treated with exsanguination transfusion for hemolytic disease of the newborn. II. Intellectual abilities and speech defects].
    Trávníková M
    Cesk Pediatr; 1969 Dec; 24(12):1073-9. PubMed ID: 4188574
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical EEG correlations in 67 infants treated by exchange transfusion therapy for icterus gravis neonatorum and followed since birth].
    Parigi S
    Riv Neurobiol; 1968; 14(1):114-7. PubMed ID: 5754564
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differential courses of development in children born with hemolytic disease of newborn].
    Rösler HD; Springstein HJ
    Zentralbl Gynakol; 1988; 110(1):25-34. PubMed ID: 3354275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Remote results of the treatment of hemolytic disease of the newborn. Clinico-statistical study].
    Mondo F; Cattaneo GM; Lucci Chiarissi U
    Minerva Ginecol; 1969 Apr; 21(8):453-9. PubMed ID: 5815435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Follow-up studies of children treated with exchange transfusion after birth].
    Twarowska I; Jerzykowska K; Breborowicz A
    Pediatr Pol; 1966 Mar; 41(3):271-9. PubMed ID: 5949332
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new therapeutic possibility in Rh-isoimmune hemolytic disease of the newborn. The use of Rh-positive blood based on the study of free anti-D antibody in the newborn infant. (Preliminary note)].
    Pataki L; Kaiser G; Virág I; Román F
    Orv Hetil; 1967 Feb; 108(8):352-4. PubMed ID: 6041608
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythroblastosis fetalis and hyperbilirubinemia. A five-year follow-up with neurological, psychological, and audiological evaluation.
    Johnston WH; Angara V; Baumal R; Hawke WA; Johnson RH; Keet S; Wood M
    Pediatrics; 1967 Jan; 39(1):88-92. PubMed ID: 6066698
    [No Abstract]   [Full Text] [Related]  

  • 17. [School achievement following hemolytic disease in the newborn].
    Rösler HD; Springstein HJ
    Padiatr Grenzgeb; 1990; 29(1):3-11. PubMed ID: 2342816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemolytic disease of the newborn due to anti-c.
    Saenz RB
    J Tenn Med Assoc; 1993 Jan; 86(1):9-11. PubMed ID: 8455385
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of mixed hyperbilirubinemia in neonatal hemolytic disease caused by Rh materno-fetal isoimmunization].
    Centa A
    Pathologica; 1967; 59(879):513-8. PubMed ID: 5634190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.